![](/ServeContent?url=http%3A%2F%2Farchfami.ama-assn.org%2Ficons%2Fspacer.gif) |
![](/ServeContent?url=http%3A%2F%2Farchfami.ama-assn.org%2Ficons%2Fspacer.gif) |
![](/ServeContent?url=http%3A%2F%2Farchfami.ama-assn.org%2Ficons%2Fspacer.gif)
Practice Commentary
Julienne K. Kirk, PharmD
Arch Fam Med. 1995;4(10):843.
![](/ServeContent?url=http%3A%2F%2Farchfami.ama-assn.org%2Ficons%2Fspacer.gif) |
![](/ServeContent?url=http%3A%2F%2Farchfami.ama-assn.org%2Ficons%2Fspacer.gif) |
Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
![](/ServeContent?url=http%3A%2F%2Farchfami.ama-assn.org%2Ficons%2Fspacer.gif) |
![](/ServeContent?url=http%3A%2F%2Farchfami.ama-assn.org%2Ficons%2Fspacer.gif) |
Below is a list of inhalers that are commonly used for the treatment of ambulatory asthma (Table).1 The class of topical inhaled corticosteroids are anti-inflammatory agents and are considered first-line therapy. β2-Selective agonists are bronchodilating agents and are the most effective agents for acute bronchospasm and exercise-induced asthma. β2-Agonists have no anti-inflammatory properties. Cromolyn sodium and nedocromil sodium are effective inhaled agents that have antiinflammatory activity but no bronchodilating effects. Ipratropium bromide is a weak bronchodilator that may be used as a supplement to a β-agonist.
. . . [Full Text PDF of this Article]
Author Affiliations
Bowman Gray School of Medicine Winston-Salem, NC
|